Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — November 2025

Genmab — November 2025

Planlagt Fastgjort Låst Flyttet Genmab
176 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    peter12
    wrote on sidst redigeret af
    #145

    Som jeg hørte det, ville de komme med to nye bi-specifikke og en ny ADC med Profound linker I år ?!
    De regnede nu med peaksale på Rina-S på 2mia$ og at peto ville sælge for 1mia$ i 2029

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #146

      Ja tre nye IND’er i år er ret flot - og endda BsAb-ADC.

      1 Reply Last reply
      0
      • B Offline
        B Offline
        bikube
        wrote on sidst redigeret af
        #147

        JnJ vin FDA traditional nod for Dara Faspro in AL amyloidosis. siger Seeking Alfa.

        1 Reply Last reply
        0
        • B Offline
          B Offline
          bikube
          wrote on sidst redigeret af
          #148

          Amgen får fuld FDA godkendelse for Imdelltra i SCLC. også iflg. S.A.

          1 Reply Last reply
          0
          • B Offline
            B Offline
            bikube
            wrote on sidst redigeret af
            #149

            Amgen får fuld FDA godkendelse for Imdelltra i SCLC. også iflg. S.A.

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #150

              Epkinly gets a second-line follicular nod And AbbVie and Genmab scoop their ASH presentation with new data.
              https://www.oncologypipeline.com/apexonco/epkinly-gets-second-line-follicular-nod

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #151

                Kesimpta peak salg forventes over 6 milliarder dollars:

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #152

                  Link Preview Image
                  Novartis venter vækst på 5-6 pct. på mellemlang sigt

                  Novartis forventer samtidig, at salget af sklerosemidlet Kesimpta, som Genmab har del i, fortsat når et topsalg på mere end 6 mia. dollar.

                  favicon

                  (medwatch.dk)

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #153

                    Virkelig flot

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #154

                      Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street. https://www.investors.com/news/technology/biotech-stocks-antibody-drug-conjugates-adcs-cancer-treatment-chemotherapy/

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #155

                        Transcript : Genmabs præsentation på Jefferies Healthcare Conference med Q&A https://proinvestor.com/investornyt/1385876/transcript-genmabs-praeligsentation-paring-jefferies-healthcare-conference-med-qampa

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #156

                          ASH Late breaker for Teclistamab + Daratumumab
                          https://x.com/JacobPlieth/status/1992984045823942775/photo/1

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #157

                            @Plimsoller looks like only 6 again, i imagine you were probably hoping for something on epco, but this is nice i would say

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #158

                              seems that dump into that large auction follows huge auction in Novo?

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #159

                                ASH25 LBA-6
                                Abstract Title : Phase 3 randomized study of teclistamab plus daratumumab versus investigator’s choice
                                of daratumumab and dexamethasone with either pomalidomide or Bortezomib (DPd/DVd) in patients
                                (Pts) with relapsed refractory multiple myeloma (RRMM): Results of majestec-3
                                https://meetings-api.hematology.org/api/abstract/vmpreview/304640 Spectacular
                                ...

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  Plimsoller
                                  wrote on sidst redigeret af
                                  #160

                                  @E L Yes, it was epco I had in mind when asking a while back, but this will do 😉 Let's hope for a good run up to ASH this year, and an even stronger finish in 2025.

                                  1 Reply Last reply
                                  0
                                  • L Offline
                                    L Offline
                                    lahn1
                                    wrote on sidst redigeret af
                                    #161

                                    Havde håbet på Epco i DLBC, det havde en kærkommen julegave. Men tænker ikke de vil vente helt til EHA i Juni ??

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      Plimsoller
                                      wrote on sidst redigeret af
                                      #162

                                      Den nyhed er vel kursdrivende, så jeg tror at de kommer med den når data er modne til offentliggørelse? Er der andre bud på det?

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #163

                                        BOFA -GMAB top SMID pick with high conviction in 3 26E catalysts for >$5bn peak https://x.com/semodough/status/1993330204442316888

                                        1 Reply Last reply
                                        0
                                        • G Offline
                                          G Offline
                                          gentogen
                                          wrote on sidst redigeret af
                                          #164

                                          I US og Kina er primary endpoint OS, så det passer nok meget godt, at data skal 'modne'

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper